3-iodo-alpha-methyltyrosine has been researched along with Carcinoma, Epidermoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bossuyt, A; Deron, P; Dierickx, LO; Everaert, H; Lahoutte, T; Voordeckers, M | 1 |
| Bossuyt, A; Caveliers, V; Deron, P; Dierickx, LO; Everaert, H; Lahoutte, T; Vanhove, C | 1 |
2 trial(s) available for 3-iodo-alpha-methyltyrosine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Evaluation of the response to therapy of head and neck squamous cell carcinoma by using 3-[123I]iodo-L-alpha-methyl tyrosine and single photon emission tomography.
Topics: Aged; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Male; Methyltyrosines; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2003 |
Diagnosis of recurrent head and neck squamous cell carcinoma with 3-[123I]iodo-L-alpha-methyltyrosine SPET.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Methyltyrosines; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2001 |